Skip to main content

Table 1 Results on hospitalized RVGE cases, costs and QALYs for the original study and with new hospitalization data and herd protection

From: An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”

 

No vaccination

Vaccination

Difference

 

Individuals aged <5y

Individuals aged ≥5y

Individuals aged <5y

Individuals aged ≥5y

Individuals aged <5y

Individuals aged ≥5y

Number of hospitalized cases from the original study 1

Community accquired

2,817

161

353

161

2,464

0

Nosocomial

421

149

106

149

315

0

Number of hospitalized cases from the original study (including herd protection for children <5 years)

Community accquired

2,817

161

155

161

2,662

0

Nosocomial

421

149

23

149

398

0

Number of hospitalized cases using the updated hospitalization data (and herd protection for <5 years) 2

Community accquired

4,241

223

233

223

4,008

0

Nosocomial

634

207

35

207

599

0

Number of hospitalized cases using the updated hospitalization data and herd protection (for <25 years) 2

Community accquired

4,241

223

233

180

4,008

43

Nosocomial

634

207

35

167

599

40

Discounted cost and QALYs from the original study 1

Total costs (direct and indirect)3

9,663,000

6,519,000

2,074,000

6,519,000

7,589,000

0

Total QALYs

173

NA4

64

NA4

109

NA4

Discounted cost and QALYs from the original study (including herd protection for <5 years only)

Total costs (direct and indirect)3

€9,663,000

€6,519,000

€969,000

€6,519,000

€8,694,000

€0

Total QALYs

173

NA4

32

NA4

141

NA4

Discounted cost and QALYs using the updated hospitalization data (and herd protection <5 years) 2

Total costs (direct and indirect)3

€13,246,000

€6,937,000

€1,203,000

€6,937,000

€12,043,000

€0

Total QALYs

207

NA4

37

NA4

170

NA4

Discounted costs and QALYs using updated hospitalization data and herd protection (for <25) 2

Total costs (direct and indirect costs)3

€13,246,000

€6,937,000

€1,203,000

€6,833,000

€12,043,000

€104,000

Total QALYs

207

NA4

37

NA4

170

NA4

  1. 1Herd protection was not included in the base case analysis; 2Herd protection for individuals aged less than 5 years of age was included in the same way as in the scenario analysis of Rozenbaum et al. [1]; 3Costs are excluding vaccination costs; 4No utility losses were available for individuals aged 5 years and older and death was conservatively assumed to occur in individuals aged less than 5 years of age only in the absence of any reported deaths in older ages.